Notably, kidney cyst number did not significantly change, but cyst size showed a trend toward smaller cysts, in mice that received both anti–PD-1 and anti–CTLA-4, suggesting that combination treatment predominantly impacted cyst expansion and not cyst initiation. The gene discussed is CTLA4; the disease is cyst.